Evaluation of staging lymphadenectomy in prostate cancer. (Q52235001)

27 April 2018

title

Evaluation of staging lymphadenectomy in prostate cancer. (English)

1 reference

27 April 2018

1 reference

El-Galley RE

1

1 reference

27 April 2018

Keane TE

2

1 reference

27 April 2018

Petros JA

3

1 reference

27 April 2018

Sanders WH

4

1 reference

27 April 2018

Clarke HS

5

1 reference

27 April 2018

Cotsonis GA

6

1 reference

27 April 2018

Graham SD Jr

7

1 reference

27 April 2018

language of work or name

English

0 references

publication date

1 October 1998

1 reference

27 April 2018

published in

Urology

1 reference

27 April 2018

volume

52

1 reference

27 April 2018

issue

4

1 reference

27 April 2018

page(s)

663-667

1 reference

27 April 2018

Open pelvic lymph node dissection for prostate cancer: a reassessment.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900222-2

7 January 2021

Should we reconsider the indications for ileo-obturator node dissection with localized prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900222-2

7 January 2021

Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900222-2

7 January 2021

Evaluation of the current incidence of nodal metastasis from prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900222-2

7 January 2021

Re-evaluation of the need for pelvic lymphadenectomy in low grade prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900222-2

7 January 2021

Predicting the patient at low risk for lymph node metastasis with localized prostate cancer: an analysis of four statistical models

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900222-2

7 January 2021

Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900222-2

7 January 2021

Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900222-2

7 January 2021

Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900222-2

7 January 2021

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900222-2

7 January 2021

10.1016/S0090-4295(98)00222-2

Identifiers

DOI

1 reference

27 April 2018

1 reference

27 April 2018